Aveanna Healthcare Hits New 52-Week High of $8.68, Surges 238.4%

Aveanna Healthcare Holdings, Inc. has reached a significant milestone by hitting a new 52-week high of USD 8.68 on September 18, 2025. This achievement marks a remarkable increase in the stock's performance, reflecting a 238.4% rise over the past year, significantly outperforming the S&P 500, which has seen a gain of 17.14% during the same period.
As a small-cap company in the Pharmaceuticals & Biotechnology industry, Aveanna Healthcare has a market capitalization of USD 1,725 million. The stock's price-to-earnings (P/E) ratio stands at 25.00, indicating its valuation relative to earnings. However, the company currently does not offer a dividend yield, and its debt-to-equity ratio is notably negative at -113.64, suggesting a unique financial structure. Additionally, the return on equity is reported at -461.83%, and the price-to-book ratio is at -143.89, reflecting the company's financial metrics.

This new high underscores Aveanna Healthcare's notable performance in the market, highlighting its position within the competitive landscape of the pharmaceuticals and biotechnology sector.